Publication: 2493

Publication: 2493

Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.

PubMed

DOI

Google Scholar

Citation:: J Clin Oncol vol 21 (9) 1819-24

Year:: 2003
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:
Grants:: CA31946

Corr. Author:: H L Parnes
Authors:: H L Parnes C Cirrincione J Aisner D A Berry S L Allen J Abrams E Chuang M R Cooper M C Perry D B Duggan T P Szatrowski I C Henderson L Norton

Networks:

Study: CALGB-9140
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Aged, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Cyclophosphamide, Disease Progression, Doxorubicin, Female, Fluorouracil, Health Status, Humans, Leucovorin, Middle Aged, Neoplasm Metastasis, Prognosis, Survival, Treatment Outcome, Viscera